A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Boston Scientific Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 6,115 shares of BSX stock, worth $531,271. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,115
Previous 6,346 3.64%
Holding current value
$531,271
Previous $434,000 8.29%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $15,553 - $17,951
-231 Reduced 3.64%
6,115 $470,000
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $77,068 - $91,813
1,338 Added 26.72%
6,346 $434,000
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $41,295 - $49,080
849 Added 20.41%
5,008 $289,000
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $1.03 Million - $1.12 Million
-20,535 Reduced 83.16%
4,159 $219,000
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $1.03 Million - $1.13 Million
20,650 Added 510.63%
24,694 $1.34 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $182,343 - $202,321
4,044 New
4,044 $202,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $306,341 - $409,440
-8,693 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $86,217 - $95,070
2,108 Added 32.01%
8,693 $385,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $3.84 Million - $4.53 Million
-100,854 Reduced 93.87%
6,585 $280,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $3.96 Million - $4.4 Million
95,930 Added 833.52%
107,439 $4.66 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $83,178 - $95,381
-2,156 Reduced 15.78%
11,509 $492,000
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $215,711 - $242,621
6,116 Added 81.02%
13,665 $528,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $71,637 - $90,697
-2,161 Reduced 22.26%
7,549 $271,000
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $420,684 - $515,839
-12,215 Reduced 55.71%
9,710 $371,000
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $46,583 - $60,346
-1,543 Reduced 6.57%
21,925 $770,000
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $606,178 - $1.07 Million
23,468 New
23,468 $766,000
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $696,210 - $857,150
-19,943 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $332,358 - $411,534
10,099 Added 102.59%
19,943 $765,000
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $2,252 - $2,771
-71 Reduced 0.72%
9,844 $348,000
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $1.63 Million - $1.92 Million
-49,745 Reduced 83.38%
9,915 $382,000
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $1.6 Million - $2.05 Million
59,660 New
59,660 $1.95 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $12.7 Million - $14.4 Million
-503,669 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $11.8 Million - $14.2 Million
475,026 Added 1658.44%
503,669 $12.5 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $752,165 - $835,516
28,643
28,643 $836,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $124B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.